Safety study of a new drug for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease within the last 10 years
- You currently have or have had slow stomach emptying or ongoing constipation
- You are able to swallow multiple large pills without help
- You are on a stable dose of your regular medications (except certain Parkinson's drugs) for at least 60 days before the study starts
- You are not taking any of the following Parkinson's drugs: levodopa/carbidopa, levodopa/benserazide, or anticholinergic agents
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug, MTX325, in people with Parkinson's disease. The goal is to see if it is safe and how the body processes it, which may lead to new treatment options.
This trial tests a new oral medication for people with early-onset Parkinson's disease. It aims to see if the drug safely improves motor symptoms and quality of life compared to a placebo.
This study tests a new tablet called ENERGI-F705 to see if it helps reduce Parkinson's disease symptoms and is safe to take. You'll need to have had Parkinson's for at least 2 years and be on standard Parkinson's medications.
This trial tests a new tablet (VG081821AC) for people with early-to-mid-stage Parkinson's disease who have not recently used levodopa. The goal is to see if it can improve movement symptoms safely.
This study tests a new oral medication called EC5026 for Parkinson's disease. It aims to see if the drug is safe and if it might help control symptoms when added to your current levodopa treatment.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.